An Evidence-Based Approach to Studies in Cirrhosis and Portal Hypertension: Medical Management of Mild to Moderate Ascites

被引:2
作者
Talwalkar, Jayant A. [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
关键词
D O I
10.1016/S1542-3565(03)00225-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Previous articles in this series have examined the critical appraisal of isolated structured clinical questions using the framework of evidence-based medicine. When patients are identified with a disease-specific process, however, an integrated approach for addressing multiple questions is required. This article, the sixth in the evidence-based medicine series for this journal, integrates critical appraisal techniques to examine the decision-making process used when evaluating a patient with cirrhosis and new-onset mild to moderate ascites. In the following clinical scenario, an approach is described for determining prognosis after the development of ascites and whether salt restriction and oral diuretics are effective therapies. The format is similar to other evidence-based medicine articles published in the Journal of the American Medical Association. The evidence-based medicine concepts have been expanded from previous articles, and examples from the hepatology literature have been used.
引用
收藏
页码:474 / 479
页数:6
相关论文
共 26 条
[1]   CANRENONE AND ANDROGEN RECEPTOR-ACTIVE MATERIALS IN PLASMA OF CIRRHOTIC-PATIENTS DURING LONG-TERM K-CANRENOATE OR SPIRONOLACTONE THERAPY [J].
ANDRIULLI, A ;
ARRIGONI, A ;
GINDRO, T ;
KARBOWIAK, I ;
BUZZETTI, G ;
ARMANINI, D .
DIGESTION, 1989, 44 (03) :155-162
[2]  
APPLEFELD JJ, 1994, ALIMENT PHARM THERAP, V8, P397
[3]   SURVIVAL AND PROGNOSTIC INDICATORS IN COMPENSATED AND DECOMPENSATED CIRRHOSIS [J].
DAMICO, G ;
MORABITO, A ;
PAGLIARO, L ;
MARUBINI, E .
DIGESTIVE DISEASES AND SCIENCES, 1986, 31 (05) :468-475
[4]   Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients [J].
Fattovich, G ;
Giustina, G ;
Degos, F ;
Tremolada, F ;
Diodati, G ;
Almasio, P ;
Nevens, F ;
Solinas, A ;
Mura, D ;
Brouwer, JT ;
Thomas, H ;
Njapoum, C ;
Casarin, C ;
Bonetti, P ;
Fuschi, P ;
Basho, J ;
Tocco, A ;
Bhalla, A ;
Galassini, R ;
Noventa, F ;
Schalm, SW ;
Realdi, G .
GASTROENTEROLOGY, 1997, 112 (02) :463-472
[5]  
FIACCADORI F, 1993, CLIN INVESTIGATOR, V71, P579
[6]  
Gentilini P, 1997, AM J GASTROENTEROL, V92, P66
[7]   ADVANTAGES OF THE NEW LOOP DIURETIC TORASEMIDE OVER FUROSEMIDE IN PATIENTS WITH CIRRHOSIS AND ASCITES - A RANDOMIZED, DOUBLE-BLIND CROSS-OVER TRIAL [J].
GERBES, AL ;
BERTHEAUREITHA, U ;
FALKNER, C ;
JUNGST, D ;
PAUMGARTNER, G .
JOURNAL OF HEPATOLOGY, 1993, 17 (03) :353-358
[8]   COMPENSATED CIRRHOSIS - NATURAL-HISTORY AND PROGNOSTIC FACTORS [J].
GINES, P ;
QUINTERO, E ;
ARROYO, V ;
TERES, J ;
BRUGUERA, M ;
RIMOLA, A ;
CABALLERIA, J ;
RODES, J ;
ROZMAN, C .
HEPATOLOGY, 1987, 7 (01) :122-128
[9]   Rating the quality of evidence for clinical practice guidelines [J].
Hadorn, DC ;
Baker, D ;
Hodges, JS ;
Hicks, N .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (07) :749-754
[10]   An evidence-based medicine approach to economic studies: assessing the cost-effectiveness of competing strategies for colorectal cancer screening [J].
Inadomi, John M. ;
Sonnenberg, Amnon .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2003, 1 (05) :404-413